BOP2-DC: Bayesian optimal phase II designs with dual-criterion decision making

12/20/2021
by   Yujie Zhao, et al.
0

The conventional phase II trial design paradigm is to make the go/no-go decision based on the hypothesis testing framework. Statistical significance itself alone, however, may not be sufficient to establish that the drug is clinically effective enough to warrant confirmatory phase III trials. We propose the Bayesian optimal phase II trial design with dual-criterion decision making (BOP2-DC), which incorporates both statistical significance and clinical relevance into decision making. Based on the posterior probability that the treatment effect reaches the lower reference value (statistical significance) and the clinically meaningful value (clinical significance), BOP2-DC allows for go/consider/no-go decisions, rather than a binary go/no-go decision, and it is optimized to maximize the probability of a go decision when the treatment is effective or minimize the sample size when the treatment is futile. BOP2-DC is highly flexible and accommodates various types of endpoints, including binary, continuous, time-to-event, multiple, and co-primary endpoints, in single-arm and randomized trials. Simulation studies show that the BOP2-DC design yields desirable operating characteristics. The software to implement BOP2-DC is freely available at <www.trialdesign.org>.

READ FULL TEXT
research
08/21/2019

Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance

Background: Well-designed phase II trials must have acceptable error rat...
research
10/01/2018

TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer Immunotherapy

Immunotherapies have revolutionized cancer treatment. Unlike chemotherap...
research
02/14/2023

A Flexible Multi-Metric Bayesian Framework for Decision-Making in Phase II Multi-Arm Multi-Stage Studies

We propose a multi-metric flexible Bayesian framework to support efficie...
research
08/27/2019

Bayesian decision-making with multiple correlated binary outcomes in clinical trials

Clinical trials often evaluate multiple outcome variables to form a comp...
research
10/26/2020

Advancing statistical decision-making in sports science

The magnitude-based decisions (MBD) procedure was developed within sport...
research
02/21/2019

Towards More Flexible False Positive Control in Phase III Randomized Clinical Trials

Phase III randomized clinical trials play a monumentally critical role i...

Please sign up or login with your details

Forgot password? Click here to reset